Related Experiment Video
Updated: Nov 19, 2025

13:10
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
10.1K
Single-particle fibrinogen detection using platelet membrane-coated fluorescent polystyrene nanoparticles
Da Chen1, Ziyi Song, Meiling Lian
1School of Precision Instruments and Optoelectronics Engineering, Tianjin University, Tianjin, 300072, China.
Nanoscale
|January 27, 2021
Summary
A novel biosensor uses platelet-coated nanoparticles for sensitive fibrinogen detection. This method offers a new tool for diagnosing diseases linked to fibrinogen levels.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Clinical Chemistry
Background:
- Fibrinogen is crucial in physiological processes and serves as a disease biomarker.
- Sensitive fibrinogen assay methods are vital for disease diagnosis and monitoring.
Purpose of the Study:
- To develop a sensitive and selective method for fibrinogen detection.
- To utilize platelet membrane-coated fluorescent nanoparticles for a novel biosensing approach.
Main Methods:
- Developed a color-coded single-particle detection (SPD) method using platelet membrane-coated fluorescent polystyrene nanoparticles (PNPs).
- Exploited the specific interaction between fibrinogen and platelet integrin receptors to induce nanoparticle aggregation.
- Quantified fibrinogen concentration by analyzing colocalization events and Pearson's correlation coefficient of fluorescently labeled PNPs.
Main Results:
- The SPD method demonstrated a linear detection range of 30-300 μg mL⁻¹ for fibrinogen.
- Achieved a limit of detection (LOD) of 3.9 μg mL⁻¹ (11.3 nM) for fibrinogen.
- Validated the biosensor's selectivity for fibrinogen and its effectiveness in real sample applications.
Conclusions:
- The proposed platelet nanoparticle-based biosensor provides a sensitive and selective method for fibrinogen detection.
- This novel SPD approach shows promise for clinical applications in diagnosing fibrinogen-related diseases.

